Literature DB >> 33321725

Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease.

Midori Filiz Nishimura1, Takuro Igawa1, Yuka Gion2, Sakura Tomita3, Dai Inoue4, Akira Izumozaki4, Yoshifumi Ubara5, Yoshito Nishimura6, Tadashi Yoshino1, Yasuharu Sato1,2.   

Abstract

Plasma cell type idiopathic multicentric Castleman disease (PC-iMCD) occasionally manifests as parenchymal lung disease. This study aimed to elucidate the detailed clinicopathological features of lung lesions in PC-iMCD and compare the findings with those in immunoglobulin (Ig) G4-related disease (IgG4-RD), the most difficult differential diagnosis of PC-iMCD. We analyzed the clinicopathological findings and immunohistochemical expression patterns of interleukin-6 (IL-6) and Igs in lung specimens from 16 patients with PC-iMCD and 7 patients with IgG4-RD. Histologically, pulmonary PC-iMCD could not be differentiated from IgG4-RD based on lesion distribution patterns, the number of lymphoid follicles and obliterative vasculitis, or fibrosis types. The eosinophil count was higher in the IgG4-RD group than in the PC-iMCD group (p = 0.004). The IgG4/IgG-positive cell ratio was significantly higher in the IgG4-RD group (p < 0.001). The IgA-positive cell count and IL-6 expression intensity were higher in the PC-iMCD group than in the IgG4-RD group (p < 0.001). Based on these findings, we proposed a new diagnostic approach to differentiate lung lesions of PC-iMCD and IgG4-RD. Our approach can be utilized to stratify patients with suspected lung-dominant PC-iMCD to identify candidates for strong immunosuppressive treatment, including IL-6 blockade, at an early stage.

Entities:  

Keywords:  IL-6; IgG4-related disease; hyper IL-6 syndrome; immunohistochemistry; plasma cell type idiopathic multicentric Castleman disease

Year:  2020        PMID: 33321725      PMCID: PMC7768369          DOI: 10.3390/jpm10040269

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  31 in total

Review 1.  Fifty years of multicentric Castleman's disease.

Authors:  Ashita Waterston; Mark Bower
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

Review 2.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

3.  Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

Authors:  Norihiro Nishimoto; Yuzuru Kanakura; Katsuyuki Aozasa; Takeshi Johkoh; Minoru Nakamura; Shuji Nakano; Nobuaki Nakano; Yasuo Ikeda; Takeshi Sasaki; Kiyoshi Nishioka; Masamichi Hara; Hirokuni Taguchi; Yukihiko Kimura; Yoshiro Kato; Hideki Asaoku; Shunichi Kumagai; Fumio Kodama; Hideko Nakahara; Keisuke Hagihara; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
Journal:  Blood       Date:  2005-07-05       Impact factor: 22.113

4.  Clinical characterization of 52 patients with immunoglobulin G4-related disease in a single tertiary center in Japan: Special reference to lung disease in thoracic high-resolution computed tomography.

Authors:  Takeshi Saraya; Kosuke Ohkuma; Masachika Fujiwara; Chika Miyaoka; Shoko Wada; Takayasu Watanabe; Sunao Mikura; Manami Inoue; Miku Oda; Mitsuru Sada; Yukari Ogawa; Kojiro Honda; Masaki Tamura; Takuma Yokoyama; Daisuke Kurai; Haruyuki Ishii; Hajime Takizawa
Journal:  Respir Med       Date:  2017-09-25       Impact factor: 3.415

5.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

Authors:  G Frizzera; B A Peterson; E D Bayrd; A Goldman
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

6.  Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.

Authors:  N Nishimoto; M Sasai; Y Shima; M Nakagawa; T Matsumoto; T Shirai; T Kishimoto; K Yoshizaki
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

7.  Diagnostic Utility of Interleukin-6 Expression by Immunohistochemistry in Differentiating Castleman Disease Subtypes and Reactive Lymphadenopathies.

Authors:  Ginell R Post; Robert C Bell; Anwar Rjoop; Rodolfo Henrich Lobo; Youzhong Yuan; Steven R Post
Journal:  Ann Clin Lab Sci       Date:  2016-09       Impact factor: 1.256

8.  Immunoglobulin G4-related lung disease: CT findings with pathologic correlations.

Authors:  Dai Inoue; Yoh Zen; Hitoshi Abo; Toshifumi Gabata; Hiroshi Demachi; Takeshi Kobayashi; Jyun Yoshikawa; Shiro Miyayama; Masahide Yasui; Yasuni Nakanuma; Osamu Matsui
Journal:  Radiology       Date:  2009-02-12       Impact factor: 11.105

9.  Intrapulmonary Castleman's Disease Pretending to Be a Lung Cancer-Work Up of an Intrapulmonary Tumour.

Authors:  Benedikt Haager; Gian Kayser; Severin Schmid; Bernward Passlick; Sebastian Wiesemann
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-11-19       Impact factor: 1.520

10.  Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease.

Authors:  Yanyan Han; Takuro Igawa; Kyohei Ogino; Asami Nishikori; Yuka Gion; Tadashi Yoshino; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2020-03-08
View more
  4 in total

1.  Renal Cell Carcinoma-Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report.

Authors:  Yusuke Yoshimura; Tatsuya Suwabe; Daisuke Ikuma; Yuki Oba; Masayuki Yamanouchi; Akinari Sekine; Hiroki Mizuno; Eiko Hasegawa; Junichi Hoshino; Kei Kono; Keiichi Kinowaki; Kenichi Ohashi; Naoki Sawa; Yoshifumi Ubara
Journal:  Kidney Med       Date:  2022-04-29

2.  Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.

Authors:  Asami Nishikori; Midori Filiz Nishimura; Yoshito Nishimura; Kenji Notohara; Akira Satou; Masafumi Moriyama; Seiji Nakamura; Yasuharu Sato
Journal:  Pathol Int       Date:  2021-11-11       Impact factor: 2.121

3.  Historical and pathological overview of Castleman disease.

Authors:  Midori Filiz Nishimura; Yoshito Nishimura; Asami Nishikori; Tadashi Yoshino; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-04-27

4.  Immunoglobulin G4-related lymph node disease with an orbital mass mimicking Castleman disease: A case report.

Authors:  Feng-Yun Hao; Feng-Xia Yang; Hai-Yan Bian; Xia Zhao
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.